These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7855906)

  • 1. Calpain inhibition: an overview of its therapeutic potential.
    Wang KK; Yuen PW
    Trends Pharmacol Sci; 1994 Nov; 15(11):412-9. PubMed ID: 7855906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and therapeutic potential of calpain inhibitors.
    Wang KK; Yuen PW
    Adv Pharmacol; 1997; 37():117-52. PubMed ID: 8891101
    [No Abstract]   [Full Text] [Related]  

  • 3. Calpain as proposed target for neuroprotective treatment of brain ischemia.
    Zalewska T
    Folia Neuropathol; 1996; 34(3):121-7. PubMed ID: 8946783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
    Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW
    Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of calpains to myocardial ischaemia/reperfusion injury.
    Inserte J; Hernando V; Garcia-Dorado D
    Cardiovasc Res; 2012 Oct; 96(1):23-31. PubMed ID: 22787134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of calpain and proteasome inhibition on Ca2+-dependent proteolysis and muscle histopathology in the mdx mouse.
    Briguet A; Erb M; Courdier-Fruh I; Barzaghi P; Santos G; Herzner H; Lescop C; Siendt H; Henneboehle M; Weyermann P; Magyar JP; Dubach-Powell J; Metz G; Meier T
    FASEB J; 2008 Dec; 22(12):4190-200. PubMed ID: 18728218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calpain inhibition: a therapeutic strategy targeting multiple disease states.
    Carragher NO
    Curr Pharm Des; 2006; 12(5):615-38. PubMed ID: 16472152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calpain translocation and activation as pharmacological targets during myocardial ischemia/reperfusion.
    Hernando V; Inserte J; Sartório CL; Parra VM; Poncelas-Nozal M; Garcia-Dorado D
    J Mol Cell Cardiol; 2010 Aug; 49(2):271-9. PubMed ID: 20211186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and physiological function of calpains.
    Sorimachi H; Ishiura S; Suzuki K
    Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):721-32. PubMed ID: 9396712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Novel and Highly Selective Inhibitors of Calpain for the Treatment of Alzheimer's Disease: 2-(3-Phenyl-1H-pyrazol-1-yl)-nicotinamides.
    Kling A; Jantos K; Mack H; Hornberger W; Drescher K; Nimmrich V; Relo A; Wicke K; Hutchins CW; Lao Y; Marsh K; Moeller A
    J Med Chem; 2017 Aug; 60(16):7123-7138. PubMed ID: 28759231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The beta- and gamma-CH2 of B27-WT's Leu11 and Ile18 side chains play a direct role in calpain inhibition.
    Betts R; Anagli J
    Biochemistry; 2004 Mar; 43(9):2596-604. PubMed ID: 14992597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developments in the design and synthesis of calpain inhibitors.
    Neffe AT; Abell AD
    Curr Opin Drug Discov Devel; 2005 Nov; 8(6):684-700. PubMed ID: 16312145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alpha-mercaptoacrylic acid derivative (PD150606) inhibits selective motor neuron death via inhibition of kainate-induced Ca2+ influx and not via calpain inhibition.
    Van den Bosch L; Van Damme P; Vleminckx V; Van Houtte E; Lemmens G; Missiaen L; Callewaert G; Robberecht W
    Neuropharmacology; 2002 Apr; 42(5):706-13. PubMed ID: 11985829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective.
    Wang KK; Nath R; Posner A; Raser KJ; Buroker-Kilgore M; Hajimohammadreza I; Probert A W; Marcoux FW; Ye Q; Takano E; Hatanaka M; Maki M; Caner H; Collins JL; Fergus A; Lee KS; Lunney EA; Hays SJ; Yuen P
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6687-92. PubMed ID: 8692879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of a kininogen-based selective inhibitor of thrombin-induced platelet aggregation.
    Matsueda R; Umeyama H; Puri RN; Bradford HN; Colman RW
    Pept Res; 1994; 7(1):32-5. PubMed ID: 8019060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new cell-permeable calpain inhibitor.
    Fiorino F; Gil-Parrado S; Assfalg-Machleidt I; Machleidt W; Moroder L
    J Pept Sci; 2007 Jan; 13(1):70-3. PubMed ID: 17019744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calpain inhibition improves collateral-dependent perfusion in a hypercholesterolemic swine model of chronic myocardial ischemia.
    Sabe AA; Potz BA; Elmadhun NY; Liu Y; Feng J; Abid MR; Abbott JD; Senger DR; Sellke FW
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):245-52. PubMed ID: 26478238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the structure of calpain-10 and its interaction with the protease inhibitor SNJ-1715.
    da Silva RC; de Alencar NA; Alves CN; Lameira J
    Comput Biol Med; 2013 Oct; 43(10):1334-40. PubMed ID: 24034724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of calpain inhibitors.
    Donkor IO
    Curr Med Chem; 2000 Dec; 7(12):1171-88. PubMed ID: 11032966
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.